BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Ebola outbreak
Hantavirus
Trump administration impacts
Med-tech outlook 2026
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Saturday, June 6, 2026
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Sep. 8, 2017
View Archived Issues
Sarepta's phase I/II study of golodirsen in DMD meets primary biological endpoint
Read More
GSK exercises option to develop and commercialize SPEAR T-cell therapy program targeting NY-ESO
Read More
Phase IIb trial of upadacitinib in atopic dermatitis meets primary endpoint
Read More
Intra-Cellular Therapies reports data from first part of lumateperone study
Read More
Clinical results presented for JNJ-42847922/MIN-202 in insomnia and major depression
Read More
Tyme reports positive results from long-term analysis of SM-88 trial in metastatic cancer
Read More
Boehringer Ingelheim and Gubra to develop treatments for obesity
Read More
Rutgers University discovers novel chemical entities for treating tuberculosis
Read More
Iovance Biotherapeutics and Ohio State University enter preclinical research collaboration
Read More
Novartis presents new analyses on AMG-334
Read More
FDA awards breakthrough therapy designation to cemiplimab for advanced CSCC
Read More
Amylyx Pharmaceuticals enters collaboration with Project ALS
Read More
SBIR grant supports Oligomerix's development of Alzheimer's disease specific antibody biomarker
Read More
VSV-GP shows promising in vitro results for the treatment of lung cancer
Read More
FDA places clinical hold on durvalumab studies
Read More
Lyndra and Allergan partner to develop ultra-long-acting Alzheimer's treatment
Read More
Alnylam updates status of fitusiran and givosiran development programs
Read More
Bristol-Myers Squibb completes acquisition of IFM Therapeutics
Read More
miRNAs found to impact MDD treatment response
Read More
Shanghai Institute Materia Medica discovers new FGFR inhibitors
Read More
Sumitomo Dainippon Pharma generates novel imidazolylamide derivatives
Read More
New 5' AMP-activated protein kinase activators discovered at Shionogi & Co.
Read More
R-Pharm CJSC presents novel serine/threonine-protein kinase B-raf inhibitors
Read More
Asceneuron patents N-acetyl-beta-D-glucosaminidase inhibitors
Read More
Eisai and Ono collaborate to develop Lenvima and Opdivo combination for HCC
Read More
